Thiamiprine

Thiamiprine

SCHEMBL28095327

Cn1cnc([N+](=O)[O-])c1Sc1nc(=N)[nH]c2[nH]cnc12.S

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.53
LMNA P02545 2/20 0.53
HBB P68871 2/20 0.53
GMNN O75496 1/20 0.53
TP53 P04637 1/20 0.53
PGR P06401 1/20 0.53
CYP3A4 P08684 1/20 0.53
SLC6A4 P31645 1/20 0.53
BLM P54132 1/20 0.53
PMP22 Q01453 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
ALDH1A1 P00352 6/20 0.47
ATM Q13315 2/20 0.46
HTT P42858 2/20 0.46
RAB9A P51151 1/20 0.46
HPGD P15428 2/20 0.46
GFER P55789 3/20 0.45
CYP2C19 P33261 2/20 0.45
CYP2C9 P11712 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Thiamiprine SCHEMBL27866409 0.85 MAPT (0.47) MAPTLMNAHBBGMNNTP53
Thiamiprine SCHEMBL28239157 0.80 MAPT (0.41) MAPTLMNAHBBGMNNTP53
Thiamiprine SCHEMBL4852 0.76 CYP1A2 (0.56) MAPTLMNAHBBGMNNTP53
Thiamiprine SCHEMBL29350246 0.76 CYP1A2 (0.56) MAPTLMNAHBBGMNNTP53
Azathioprine SCHEMBL3261116 0.74 MAPT (0.68) MAPTLMNAHBBGMNNTP53
Azathioprine SCHEMBL29693611 0.70 MAPT (1.00) MAPTLMNAHBBGMNNTP53
Azathioprine SCHEMBL4278 0.70 MAPT (1.00) MAPTLMNAHBBGMNNTP53
Azathioprine SCHEMBL4436347 0.70 MAPT (1.00) MAPTLMNAHBBGMNNTP53
Thiamiprine SCHEMBL4851 0.70 MAPT (0.71) MAPTLMNAHBBGMNNTP53
Azathioprine SCHEMBL3089846 0.69 MAPT (0.98) MAPTLMNAHBBGMNNTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105848680-A Treatment using bruton's tyrosine kinase inhibitors and immunotherapy 药品循环有限责任公司 2016-08-10 CN disclosed